MedTrace Logo

Observational Study Investigating the Effectiveness of Fentanyl Matrix in Relieving Pain and Improving Function in Patients With Osteoarthritis of the Knee or Hip

NCT01119885 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 742

Last updated 2014-04-28

No results posted yet for this study

Summary

The purpose of this study is to investigate the utility of fentanyl matrix for the treatment of pain due to osteoarthritis (OA) of knee or hip, which was not adequately controlled by non-opioid analgesic (e.g. NSAIDs or COX-II inhibitors) or weak opioids \[tramadol HClacetaminophen, tramadol or codeine (or combinations with acetaminophen/ibuprofen)\].

Conditions

  • Pain
  • Osteoarthritis, Hip
  • Osteoarthritis, Knee

Interventions

DRUG

fentanyl matrix

Knee osteoarthritis, starting with 12mcg/h (flexible dose)

DRUG

fentanyl matrix

Hip osteoarthritis, starting with 12mcg/h (flexible dose)

Sponsors & Collaborators

  • Janssen Korea, Ltd., Korea

    lead INDUSTRY

Principal Investigators

  • Janssen Korea, Ltd. Clinical Trial · Janssen Korea, Ltd.

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-01-31
Completion
2009-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01119885 on ClinicalTrials.gov